Haptoglobin testing in hemolysis: Measurement and interpretation

American Journal of Hematology

Volumn 89, Issue 4, 2014, Pages 443-447

  Shih, Andrew W Y ^a   Mcfarlane, Andrew ^a   Verhovsek, Madeleine ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; CORTICOSTEROID; ESTROGEN; HAPTOGLOBIN; HEMOPEXIN; PEROXIDASE;

ARTICLE; B LYMPHOCYTE; DISULFIDE BOND; GEL ELECTROPHORESIS; GENOTYPE; GLOBULIN BLOOD LEVEL; HELPER CELL; HEMAGGLUTINATION; HEMODILUTION; HEMOLYSIS; HUMAN; HYPERSPLENISM; IMMUNODIFFUSION; IMMUNOREACTIVITY; LIGHT ABSORPTION; LIVER CELL; LIVER CIRRHOSIS; MOLECULAR SIZE; NONHUMAN; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SICKLE CELL ANEMIA; SPECTROPHOTOMETRY; SPLENOMEGALY;

ANEMIA, HEMOLYTIC; BLOOD PROTEIN ELECTROPHORESIS; DIAGNOSIS, DIFFERENTIAL; ELECTROPHORESIS, AGAR GEL; FALSE NEGATIVE REACTIONS; FALSE POSITIVE REACTIONS; HAPTOGLOBINS; HEMOGLOBINS; HEMOLYSIS; HUMANS; IMMUNODIFFUSION; PROTEIN BINDING; REPRODUCIBILITY OF RESULTS; SPECTROPHOTOMETRY;

EID: 84897446339     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.23623     Document Type: Article

References (37)

1. Polonovski M, Jayle MF. Existence dans le plasma sanguin d'une substance activant l'action peroxydasique de l'hemoglobine. Comptes Rendus des Seances de la Societe de Biologie et de Ses Filiales 1938:457-460.
2. Tolosano E, Fagoonee S, Hirsch E, et al. Enhanced splenomegaly and severe liver inflammation in haptoglobin/hemopexin double-null mice after acute hemolysis. Blood 2002;100:4201-4208.
3. Nielsen MJ, Moestrup SK. Receptor targeting of hemoglobin mediated by the haptoglobins: Roles beyond heme scavenging. Blood 2009;114:764-771.
4. Bensi G, Raugei G, Klefenz H, Cortese R. Structure and expression of the human haptoglobin locus. EMBO J 1985;4:119-126.
5. Carter K, Worwood M. Haptoglobin: A review of the major allele frequencies worldwide and their association with diseases. Int J Lab Hematol 2007;29:92-110.
6. Kalmovarin N, Friedrichs WE, O'Brien HV, et al. Extrahepatic expression of plasma protein genes during inflammation. Inflammation 1991;15:369-379.
7. Yang F, Friedrichs WE, Navarijo-Ashbaugh AL, et al. Cell type-specific and inflammatory-induced expression of haptoglobin gene in lung. Lab Invest 1995;73:433-440.
8. Mitani K, Fujita H, Kappas A, Sassa S. Heme oxygenase is a positive acute-phase reactant in human Hep3B hepatoma cells. Blood 1992;79:1255-1259.
9. Rother RP, Bell L, Hillmen P, Gladwin MT. The clinical sequelae of intravascular hemolysis and extracellular plasma hemoglobin: A novel mechanism of human disease. JAMA 2005;293:1653-1662.
10. Balla J, Jacob HS, Balla G, et al. Endothelial-cell heme uptake from heme proteins: induction of sensitization and desensitization to oxidant damage. Proc Natl Acad Sci USA 1993;90:9285-9289.
11. Sadrzadeh SM, Graf E, Panter SS, et al. Hemoglobin. A biologic fenton reagent. J Biol Chem 1984;259:14354-14356.
12. Kato GJ, Gladwin MT, Steinberg MH. Deconstructing sickle cell disease: Reappraisal of the role of hemolysis in the development of clinical subphenotypes. Blood Rev 2007;21:37-47.
13. Lim SK, Kim H, Bin Ali A, et al. Increased susceptibility in Hp knockout mice during acute hemolysis. Blood 1998;92:1870-1877.
14. Wagener FA, da Silva JL, Farley T, et al. Differential effects of heme oxygenase isoforms on heme mediation of endothelial intracellular adhesion molecule 1 expression. J Pharmacol Exp Therapeutics 1999;291:416-423.
15. Wassell J. Haptoglobin: Function and polymorphism. Clin Lab 2000;46:547-552.
16. Kormoczi GF, Saemann MD, Buchta C, et al. Influence of clinical factors on the haemolysis marker haptoglobin. Eur J Clin Invest 2006;36:202-209.
17. Dobryszycka W. Biological functions of haptoglobin-New pieces to an old puzzle. Eur J Clin Chem Clin Biochem 1997;35:647-654.
18. Beisembaeva RU, Mursagalieva AT, Dzhumalieva LM, et al. Identification of haptoglobin as an endogenous inhibitor of prostaglandin H synthase in the cytosol fraction of primary cells from sheep vesicular glands. FEBS Lett 1990;269:125-127.
19. Arredouani M, Matthijs P, Van Hoeyveld E, et al. Haptoglobin directly affects T cells and suppresses T helper cell type 2 cytokine release. Immunology 2003;108:144-151.
20. Cid MC, Grant DS, Hoffman GS, et al. Identification of haptoglobin as an angiogenic factor in sera from patients with systemic vasculitis. J Clin Invest 1993;91:977-985.
21. Kickler TS, Gong PF, Johnson GF, Solomon HM. Kinetic determination of serum haptoblobin with a centrifugal analyzer. Clin Chem 1976;22:1962-1967.
22. Valeri CR, Bond JC, Fowler K, Sobucki J. Quantitation of serum hemoglobin-binding capacity using cellulose acetate membrane electrophoresis. Clin Chem 1965;11:581-588.
23. Lionetti FJ, Valeri CR, Bond JC, Fortier NL. Measurement of hemoglobin binding capacity of human serum of plasma by means of dextran gels. J Lab Clin Med 1964;64:519-528.
24. Elson EC. Quantitative determination of serum haptoglobin. A simple and rapid method. Am J Clin Pathol 1974;62:655-663.
25. Ali MA, Vanderlinder B. Diagnosis of intravascular haemolysis using starch gel electrophoresis. Scandinavian J Haematol 1977;19:343-346.
26. Sakata M, Yoshida A, Haga M. Methemoglobin in blood as determined by double-wavelength spectrophotometry. Clin Chem 1982;28:508-511.
27. Braun HJ, Aly FW. Problems in the quantitative estimation of human serum haptoglobin by single radial immunodiffusion. Clinica chimica acta 1969;26:588-950.
28. Van Lente F, Marchand A, Galen RS. Evaluation of a nephelometric assay for haptoglobin and its clinical usefulness. Clin Chem 1979;25:2007-2010.
29. Denham E, Mohn B, Tucker L, et al. Evaluation of immunoturbidimetric specific protein methods using the Architect ci8200: Comparison with immunonephelometry. Annals Clin Biochem 2007;44:529-536.
30. Goyal MM, Basak A. Estimation of plasma haemoglobin by a modified kinetic method using o-tolidine. Indian J Clin Biochem 2009;24:36-41.
31. Cox M. A study of the sensitivity and specificity of four presumptive tests for blood. J Forensic Sci 1991;36:1503-1511.
32. Marchand A, Galen RS, Van Lente F. The predictive value of serum haptoglobin in hemolytic disease. JAMA 1980;243:1909-1911.
33. Tuck CH, Holleran S, Berglund L. Hormonal regulation of lipoprotein(a) levels: Effects of estrogen replacement therapy on lipoprotein(a) and acute phase reactants in postmenopausal women. Arteriosclerosis Thrombosis Vascular Biol 1997;17:1822-1829.
34. Gupta S, Ahern K, Nakhl F, Forte F. Clinical usefulness of haptoglobin levels to evaluate hemolysis in recently transfused patients. Adv Hematol 2011;2011:389854.
35. Barbosa J, Seal US, Doe RP. Effects of anabolic steroids on haptoglobin, orosomucoid, plasminogen, fibrinogen, transferrin, ceruloplasmin, alpha-1-antitrypsin, beta-glucuronidase and total serum proteins. J Clin Endocrinol Metabolism 1971;33:388-398.
36. Hogevold HE, Kierulf P, Ovstebo R, Reikeras O. Acute phase reactants and interleukin 6 after total hip replacement. Effects of high dose corticosteroids. Eur J Surgery Acta chirurgica 1992;158:339-345.
37. Warkentin DL, Marchand A, Van Lente F. Serum haptoglobin concentrations in concurrent hemolysis and acute-phase reaction. Clin Cchem 1987;33:1265-6.